neuromotion bv develops, sells and services equipment and services for the study and treatment of human brain function in clinical and research applications. The company focuses on products with a high impact of innovation and technology. Our business is rooted in the application of key diagnostic and treatment technologies such as electroencephalography (EEG) and magnetoencephalography (MEG), magnetic resonance imaging (MRI), and transcranial magnetic stimulation (TMS).

Using our products, functional information as obtained from EEG recordings is applied to gain deeper insight into brain functions, to improve or modulate cognitive and physical performance, and to treat brain and mental disorders. Our products offer a broad range of diagnostic and therapeutic applications in cognitive neuroscience, sport and movement science, neurology and psychiatry.

ANT Neuro (Enschede - The Netherlands), ANT Neuro UK (London, United Kingdom), ANT Benelux (Enschede - The Netherlands), ANT North America (Madison, WI - USA), ANT Asia Pacific (Hong Kong) and eemagine GmbH (Berlin - Germany) are members of the neuromotion group. While eemagine is responsible for the development, production and support of all ANT projects, takes care of a few key accounts and is an established organization for OEM development projects for third parties situated worldwide, ANT Neuro together with ANT North America and ANT Asia Pacific are responsible for the world-wide sales and marketing of eemagine’s neuroscience, neurocare and neuromodulation products. ANT Neuro is also the marketed brand under the umbrella of the neuromotion group. The combination of the entities forms fertile grounds for innovation, remarkable product developments and collaborations.

members of the neuromotion group:        www.ant-neuro.com                 www.eemagine.com

www.ant-na.com                 www.ant-ap.com

www.ant-neuro.co.uk